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During the past  5  years we have  collected 6  strains  of the virus 
of poliomyelitis and we have observed certain characteristics which 
differentiate some from the others. 
Two of these strains (namely those isolated in New York and Con- 
necticut in  1931)  have already been compared with another pair of 
them  representing more widely known strains  of the  virus  (1).  It 
has  seemed justifiable,  however, to  pursue  the  comparisons  further 
because the strain differences are considerable and poorly understood. 
In poliomyelitis there is as yet no standard or recognized method 
whereby strains of the virus may be classified.  Their properties are 
manifold and  there  is  no  indication as  to  which is  of the  greatest 
taxonomic importance.  Thus,  an  outstanding  property  of  a  given 
strain is that of maximum virulence for the monkey on intracerebral 
inoculation.  However, virulence by this  route does not necessarily 
parallel virulence by the nasal or the cutaneous routes, to which latter 
fact one of our strains bears witness (2).  But for purposes of classifi- 
cation, besides comparing virulence by different routes of inoculation, 
it is obvious that one should use the immunological approach, for it 
is generally the method of choice in classifying substrains of infectious 
agents.  It has,  nevertheless, been evident  from the start  that  cer- 
tain features of the immunology of experimental poliomyelitis render 
this approach difficult.  It is recognized, for instance, that although 
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sera  of  convalescent  monkeys  usually  effect  neutralization,  irregu- 
larities have been reported (3-5).  It is  also recognized that the vac- 
cination of monkeys with the virus results not only in the  irregular 
production of immunity to infection, but in the irregular production 
of  humoral  antibodies,  and,  furthermore,  that  these  two  responses 
do not necessarily go hand in hand as the reports,  among others, of 
Olitsky and  Cox  (6),  Sabin  and  Olitsky  (5),  Hudson, Lennette and 
Gordon  (7)  and  Kramer  et  al.  (8)  bear  witness.  In  spite  of  these 
obvious  objections  one  gathers,  from  Aycock and  Kagan  (9)  and 
Stewart and Rhoads (10), that the artificial immunization of monkeys 
appears  to  afford the  best  method available  for the  immunological 
comparison of  strains,  and, moreover,  it  has been  successfully used 
by Kramer  (11). 
Consequently, following this method we vaccinated monkeys with 
the  virus  and later  collected the presumably immune  serum.  This 
was  saved  until  sera  representing  each  strain  were  in  hand.  Then 
after a  lapse of 12 to  18 months the appropriate  neutralization tests 
were done.  In the interim the vaccinated animals were tested by a 
series of intracerebral  inoculations for resistance to homologous and 
heterologous strains.  This last took 12 months to complete and the 
outcome was difficult to interpret,  but the results of the neutraliza- 
tion  tests seem reasonably clear  and  as  such  they form the  subject 
of this  report. 1 
Methods 
"Immunization" or "Vaccination"  of Monkeys.---6 groups of from 2 to 4 monkeys 
each were inoculated  intracutaneously with each of our 6 strains of virus.  At 
least 1 animal was inoculated  with live virus  and, following the suggestion  of 
Brodie (12), 1 animal with formalinized virus.  This was prepared in saline from a 
20 per cent suspension of spinal cord ground with sand in a mortar.  The suspen- 
sion was centrifugalized at moderate speed, 1600 R.P.~., for 6 to 8 minutes, and to 
1 cc. of the opalescent supernatant fluid 1 cc. of 0.2 per cent formalin  (0.08 per 
cent formaldehyde) in saline was added and the mixture was allowed to stand in 
the ice box for 24 hours before using. 
t The results of the series of intracranial reinoculations appear in Appendix B 
but not in the body of the paper because they did not yield information of value 
for  the  immunological classification.  They are  presented  in  graphic  form in 
Appendix B and described briefly there in order to show that they do not furnish 
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Live virus was given in saline as a  10  per cent suspension prepared within 
2 hours of inoculation. 
In each instance 2 cc. of the 10 per cent suspension (either formalinized or live) 
were inoculated in 10 piqfires into the shaved abdominal skin of rkesus monkeys. 
Each animal being immunized received 2 such doses at an interval of 2 weeks. 
Samples of blood to be used for testing for the presence or absence of neutralizing 
substances were taken prior to the  1st vaccinating dose and 2  weeks after the 
2nd dose. 
Description of Strains.----6 strains of the virus of poliomyelitis were used.  In 
describing them we realize that the respective virulence of each does not represent 
a  fixed quantity and that no satisfactory standards of virulence in experimental 
poliomyelitis have been set up.  When certain of our strains had not been passed 
for several months, their virulence diminished and sometimes massive doses were 
necessary to recover them. 
McC.  Strain,  Los Angeles, California,  1934.--This  "human ''~ strain  was  re- 
covered from the nasopharynx of a child during a mild abortive attack of polio- 
myelitis; the isolation and first few passages have been described (13).  Material 
used  for  vaccination  and  subsequent  intracerebral  testing  of  the  vaccinated 
monkeys came from a  single monkey (C 6-7, Dec. 3,  1934) 3 and represented the 
3rd passage of the strain.  The dose (for intracerebral inoculation) was 0.5 cc. 
of a  10  per cent suspension.  The  experimental disease produced by this and 
subsequent  passages  was  definite,  though  not  severe.  The  incubation  period 
was from 3 to 5 days,  the febrile period from 3 to 6 days and the animals seldom 
developed complete paralysis of all 4 limbs.  A  few attempts to infect monkeys 
by the nasal and cutaneous routes proved unsuccessful. 
During the interim between preparing sera and performing the neutralization 
tests this strain died out, and recourse w~ had to another line of passage which 
had been carried on in another laboratory.  4 
Eventually 8th passage material (monkey 4-44, Mar. 23, 1936) was used in the 
neutralization tests.  In respect to incubation period and type of experimental 
disease produced, this passage behaved the same as the earlier ones.  The dose 
employed consisted in equal parts of (a) a  10 per cent virus suspension, and (b) 
serum to be tested.  The mixtures were held for 2 hours in the incubator (37°C.) 
and inoculated intracerebrally  in 0.5 cc. amounts. 
2 There is no standard definition of "human"  and "passage" in experimental 
poliomyelitis.  We have taken human to refer to strains not far removed from 
man and which usually do not lead to death of the monkey; passage to designate 
those strains which are well established in the monkey and which usually give rise 
to fatal experimental infection. 
3 In this and similar notations the date, Dec. 3, 1934, refers to the day the cord 
was harvested. 
4 We are indebted to Dr.  Leslie T. Webster of The Rockefeller Institute for 
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Wfd. Strain, Los Angeles, California,  1934.--This human strain was recovered 
from the medulla and spinal cord of a  girl dead on the 6th day of poliomyelitis. 
Material for vaccination represented the 3rd passage (monkey C  5-5,  Nov.  10, 
1934).  Material  for  subsequent  intracerebral testing  of  vaccinated  monkeys 
represented the 3rd passage  (monkey C  5-5), the 4th passage (monkey C  1-03, 
July 28, 1935) and the 5th passage (monkey C 1-08, Aug. 14, 1935).  Mention (2) 
has been made of the high intracutaneous infectivity of this strain; on subsequent 
passage  it  has  produced  experimental  poliomyelitis more  consistently  when 
injected intracutaneously than has been noted with any of our other strains.  The 
dosage used for intracerebral inoculation and  the type of experimental disease 
produced were the same as with the McC. strain. 
For neutralization tests 6th passage material was used (monkey C  1-20,  Nov. 
24, 1935).  The dose was the same as in the neutralization test with McC. strain. 
We. Strain, New Haven, Connecticut, 1931.--This human strain was recovered 
from the nasopharynx of a  child suffering from a  mild abortive attack of polio- 
myelitis; the isolation (14) and early passages (15) have been described.  Material 
for  vaccination  and  subsequent  intracerebral  testing  of  vaccinated  monkeys 
represented the 9th passage (monkey C  7-4,  Dec.  11,  1934).  The experimental 
disease produced by this strain generally has been mild and  characterized by 
features which recall those of the McC. and Wfd. strains. 
For neutralization tests,  material from  the  9th  passage was  used  (monkey 
C  1-25, Dec. 14, 1935) in the same dose as with the McC. and Wfd. strains. 
Flexner Strain, New York, 1931.--This "passage" strain was recovered from the 
medulla and spinal cord of a  fatal human case in the epidemic of 193t  in New 
York.  5  When used for vaccination the strain was in its llth passage (monkey 
C 8-1,Jan.24,1935).  Material for subsequent intracerebral testing of vaccinated 
monkeys  represented  the  llth  passage (monkey C  8-1)  and  the  12th passage 
(monkey C  1-06, Aug. 4,  1936).  The intracerebral test dose was 0.5 cc. of a 0.5 
per cent suspension.  During the early passages this strain had maintained an 
intracerebral virulence comparable to that of the We. strain and at that time was 
considered as a human strain (1, 15), but by the 10th passage the virulence of the 
Flexner strain became enhanced in that it generally gave rise to extensive paralysis 
and often ultimately to death of the infected animal. 
For neutralization tests, 15th passage material was used (monkey 4-91, May 9, 
1936).  The dose consisted of 0.5 cc. of equal parts of (a) 1 per cent virus, and (b) 
serum to be tested (10 per cent virus used June 1 proved too strong). 
Aycock  Strain,  Vermont,  1921.--This well known and virulent passage strain 
was received in 1931. s  It was recovered in the fall of 1921 from a case in Vermont 
and has been subjected to many more passages in the monkey than any of the 
5 This strain was received by us in  1932 through  the kindness of Dr.  Simon 
Flexner of The Rockefeller Institute. 
e This strain was received through the kindness of Dr. W. L. Aycock of The 
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strains mentioned above.  The exact number of passages is not known, "perhaps a 
hundred"  (16).  The experimental disease which followed its use was severe and 
generally fatal and, in this respect, was similar to that produced by the  Flexner 
and Park strains. 
For vaccination, material from monkey C  8-2  (Jan. 29,  1935)  was used.  For 
subsequent intracerebral testing of vaccinated monkeys, material from C 8-2 and 
from the next passage (monkey C 1-07, July 29, 1935) was used in a dose of 0.5 cc. 
of a 0.5 per cent suspension. 
For the neutralization tests material from another passage was used (monkey 
4-89, May 7, 1936).  The dose consisted of 0.5 cc. of equal parts of (a) 1 per cent 
virus suspension and (b) serum to be tested; as in the Flexner strain. 
Park Strain.--This highly virulent passage strain  ~ was received in 1931  when 
it had already been subjected to many passages in the monkey.  It is a  mixed 
strain and so the date of its primary isolation and the actual number of passages 
is unknown.  It caused extensive paralysis of almost all infected monkeys and 
there were very few survivors. 
For vaccination, material from monkey C  8-0 (Jan. 22,  1935)  was used.  For 
subsequent  testing of vaccinated monkeys,  material from  C  8-0 and  from  the 
next and the 2nd following passages (monkey C  1-05, July 30, 1935, and monkey 
C  1-21, Nov. 19, 1935) was used.  The dose varied from 0.5 cc. of  10 per cent to 
0.5 cc. of 0.1 per cent suspension.  For the neutralization tests, material from a 
later passage  was  used  (monkey  5-10,  June  9,  1936).  The  dose  consisted of 
0.5 cc. of a mixture of equal parts of (a) 0.2 per cent virus and (b) the serum to be 
tested. 
Comparative neutralization tests with human  sera have been reported already 
wherein the We., Flexner, Aycock and Park strains were designated respectively, 
W, F, Aycock and M  (1). 
Experimental  Animals.S--Macacus rhesus monkeys of 2  to 3  kilos were used 
throughout for the production and testing of the antisera.  As is not unusual in 
experimental poliomyelitis certain animals were used more than once.  As regards 
the propriety of doing this, it is pertinent to state that daily temperature readings 
were taken for 4  weeks from the day of inoculation and  also that  2  observers 
independently exercised the monkeys daily for as long as the animals were in 
stock, which frequently covered a period of months.  It seemed unlikely, therefore, 
that a mild attack of the experimental disease would pass unnoticed.  However, 
this did happen to us once before (1~ ~  and apparently happened again in the case of 
monkeys 4-71 and 4-93 of this series (Appendix A).  Accordingly special mention 
of monkeys used more than once appears in Appendix A, in a  footnote. 
Preservation of MateriaL--The spinal cords and brain stems bearing the stock 
This strain was obtained through the kindness of Dr. W. H.  Park and Dr. 
E. R. Weyer, Bureau of Laboratories, Department of Health, City of New York. 
s All operations and inoculations were done under full ether anesthesia. 
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strains were kept in 30 cc. of 50 per cent glycerine in 2 ounce soft glass bottles, at 
first stoppered with rubber, but later during the period of the neutralization tests, 
with aluminum screw caps.  In the first 9  months  of this study Merck's blue 
label glycerine made up  in  saline was  used;  in  the second 9  months  this was 
replaced by Kahlbaum's glycerine diluted to 50 per cent in distilled water.  The 
stocks of virus and  serum were kept in a  refrigerator held between  2 °  and 4°C. 
Serum samples were kept without preservative in small glass bottles capped with 
"no-air" rubber stoppers. 
Neutralization  Tests.--As already stated, samples of serum were obtained from 
all vaccinated monkeys prior to the administration of the 1st vaccinating dose and 
2 weeks after the 2nd.  Neutralization tests were run on the postvaccinal samples 
of serum with the 6 stock strains of virus.  Ordinarily, for each strain, we used 
1 postvaccinal serum sample selected from a monkey vaccinated with live virus. 
As the work progressed and larger animal quarters were available, we included 
2 postvaccinal (live and formalinized) samples of serum for each strain. 
The technique employed was similar to that which we have previously described 
(1).  It may suffice to say that  the 6  strains of virus were used in  the doses 
mentioned above.  Samples of cord and brain stem from a  single monkey were 
weighed, ground in sand With the appropriate volume of saline solution and the 
suspension was centrifuged in the angle centrifuge at 1500  R.P.~. for S minutes. 
The supernatant fluid was mixed with equal parts of undiluted monkey serum. 
The mixture was placed in an incubator at 37°C. for 2 hours and monkeys were 
subsequently  inoculated  intracerebraUy  with  0.5  cc.  amounts.  Daily  tem- 
perature readings were made for a period of 4 weeks and all animals were exercised 
daily as long as they remained in the laboratory. 
In each series of tests 2  controls were included, a  protected control in which 
pooled human convalescent serum (collected October,  1931)  was mixed with the 
virus, and an unprotected control in which normal monkey serum (representing 
the prevaccinal bleeding of 1 monkey) was mixed with the virus.  The normal 
monkey serum chosen, represented the first bleeding from an animal which later 
was vaccinated with the strain of virus to be used in the current test.  Some 
attempt at titration of the virus in decimals of the test dose was included in 7 of 
the 8 tests.  The diluted virus was set up with equal volumes of the normal mon- 
key serum. 
In  the  experiment of  Jan.  17  with  the  We.  strain,  where  the  results  were 
seriously clouded by  the  occurrence of bacillary dysentery and again with the 
experiment of June  1 with the Flexner strain, when  the protected control came 
down, the series of tests was repeated. 
The  results  of  our  neutralization  tests  have  been  expressed  as  follows:  + 
signifies that neutralizing properties were present in the serum, in that the test 
animal did not  develop the experimental disease within  the  4  week period of 
observation;  -  signifies that  neutralizing properties were  absent,  in  that  the 
animal developed the experimental disease within an incubation period not more 
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period was longer than  this,  the result  was recorded  by -4-  to signify partial 
neutralization.  Thus the results were generally easy to classify but there was one 
exception; in the experiment of June 1.  Monkey 4-71 developed fever without 
other  signs of  experimental  poliomyelitis and  subsequently  resisted  another 
intracerebral inoculation of active virus.  In Appendix A this is shown as possible 
experimental  poliomyelitis. 
RESULTS 
Comparative Neutralization  Tests.--In  Table I and in the appendices 
(where more details appear)  the results of the neutralization tests are 
presented.  They are arranged so that the strains appear in 3 groups 
which  are  designated  Old,  1931  and  1934.  The  Old group  includes 
the Park and Aycock strains.  The 1931  (eastern) group includes the 
Flexner  and  We.  strains  and  the  1934  (western)  group includes  the 
Wfd.  and  McC.  strains.  By  noting  the  results  listed  under  the 
experiments of May 11 and July 13, it may be seen that the Aycock 
and  Park  strains  were  compared  by means  of 8  pairs  of tests;  in  5 
pairs  the  results were identical  and  in  3  pairs  they were somewhat 
different, but not completely so (2; ~  vs.  +  ; 1 ; -4- vs.  -).  In general, 
therefore,  the  Old strains  resembled  each other.  This  statement  is 
fortified by inspection of the table which reveals that the Old strains 
were more  closely related  to  each other than  to any of the 4  other 
strains.  Further,  it may be noticed that  the  Old strains  were well 
neutralized  by the homologous and  1934 antisera.  In fact the  Old 
strains were more frequently neutralized than were those of the other 
groups.  This  is  worth  noting  because  both  the Aycock and  Park 
strains  were  especially virulent  for monkeys  and  the effective neu- 
tralization  shown  here  suggests that  immunological  differences  be- 
tween the groups rest on a  qualitative  immunological  basis. 
The  2,  1931  strains  were compared by  6  pairs  of tests  shown  in 
Table I.  The results were identical in 4 pairs, fairly close in  1 pair 
and  dissimilar  in  1  pair.  Again,  however, inspection  of  the  table 
shows that  the  outstanding  feature is that  the  1931  strains  appear 
more closely related to each other  than to any other strains.  That 
this relationship was independent of the mere virulence of the strains 
is  indicated  in  Appendix  A,  where  the  titrations  show  that  the 
Flexner  was  considerably  more  virulent  than  the  We.  strain.  In 
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5  per  cent  virus  on  June  1,  the  protected  control  and  all  monkeys 
except  4-71  came  down  with  experimental poliomyelitis. 
The  2,  1934  strains  had  6  pairs of  tests  in  common.  The  results 
were the same in each pair of tests and as far as these experiments are 
TABLE  I 
Results of Neutralization  Tests 
sera 
Monkey 
vacci- 
nated 
with 
Old 
1931 
1934 
Vaccine 
Aycock 
C 8-2 
Park 
C 8-0 
Flexner 
C 8-1 
We. 
C 7-4 
Wfd. 
C 5-5 
IVIcC. 
C 6-7 
Vaccinated 
monkeys 
C8-7F. 
C9-8L. 
C6-2F. 
C9-4L. 
C8-8F. 
C9-9L. 
Strains of virus 
Old  1931  1934 
Aycock  Park  Flexner  We.  Wfd.  McC. 
May 11  July 13  June 19  Jan. 17;  --  I  --Feb'  21  Jan. 9  Apr. 22 
+  +  + 
:~  +  +  +  + 
+ 
+  +  -  _ 
I. 
_  _  +  +*  -  _ 
C 8-4 F.  --  -- 
C 9-3 L.  4-  -  --  -* 
C8-9 F. 
C 1-01 L. 
c8-3 F. 
C 9-2 L. 
+  +  -  + 
+  +  -  _  + 
+ 
m 
±  +  -  -t  +  + 
F., formalinized vaccine; L., live vaccine. 
-,  no protection. 
+, protection.  Results of neutralization tests. 
4-, partial protection 
+*  -*, test repeated, result confirmed. 
-~, test repeated, result first  -,  second 4.. 
concerned  the  2,  1934  strains  may  be  considered  immunologically 
identical. 
Table  I  also  shows  the  immunological  interrelationship  of  the 
groups.  It  can be seen that,  in respect to the Old antisera, the  1931 
and 1934 groups behaved similarly, but that  they differed in their own 
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pletely different if the results with the We. sera are eliminated from 
consideration.  This seems a  fair thing to do because the We. serum 
in 2 tests gave no protection against the homologous strains.  TM  There- 
fore in this connection it should be regarded as normal monkey serum. 
The 1931 and Old groupS were related by the results with the good 
Aycock and the ineffective We. antisera and separated by the results 
with the Park,  Flexner, Wfd. and McC.  antisera.  The  1934 group 
and Old group were related by all antisera except the Park.  Thus 
the  1934  strains were found to  be more closely related immunolog- 
ically to the Old than were the 1931 strains.  There is an added in- 
terest in this relationship because Kessel, Van Wart,  Fisk and Stim- 
pert (17) reported that a California strain isolated in 1935 was related, 
with merely minor immunological variations, to the well known M.V. 
virus of The Rockefeller Institute.  It is to be noted that the Flex- 
ner strain we used was not the well known M.V.  virus,  which is  a 
passage strain of many years standing, whereas ours was of relatively 
recent origin.  Thus our  results,  although  not  exactly comparable, 
are not in disagreement with those of Kessel et al.  (17). 
Comparison of the Strains as Effective  Antigens.--It can be seen in 
Table  I  that  some antisera  gave  rise  to  protection in  most  of the 
tests, whereas some other antisera were generally ineffective.  Thus 
the  Aycock antisera  were  good  whether prepared  by  live  or  for- 
malinized  vaccine.  Contrariwise the  We.  antisera  were  poor  after 
either  method  of  preparation.  The" Wfd.  and  McC.  strains  were 
moderately broad,  while the Flexner and Park  strains were narrow 
in  their antigenicity.  Naturally these apparent  differences in  anti- 
genic  efficiency could  depend  entirely on  the  individuality  of  the 
vaccinated monkeys, but  where the  results  with  the  live  and  for- 
malinized  vaccines  were  mutually  corroborative  the  outcome  was 
likely attributable  to  the virus.  Thus  it  seems probable  that  the 
Aycock strain was an unusually effective antigen.  This recalls the 
report  of  Flexner  and  Amoss  (18)  and  of  Rhoads  (19)  on  special 
immunizing strains of the virus. 
10 The partial protection in the test, on May 11, of the Aycock virus and We. 
antiserum was an inconsistency in the neutralization tests which is impossible  to 
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DISCUSSION 
The discussion will be limited to the results of the cross neutraliza- 
tion  tests,  for they concern  the major  aims of the paper which  are 
to measure and define differences between certain strains of the virus 
of poliomyelitis.  Such differences as those of intracerebral  or intra- 
nasal virulence have, of course, been long recognized, but it is a  rela- 
tively  recent  (1,  11,  15,  17,  20-23)  observation  that  so  called  im- 
munological  differences exist and it is upon these that  we have laid 
special  emphasis, n  Whether  these immunological  properties of  the 
virus  of  poliomyelitis  are  actually  more  fundamental  than  other 
measurable  properties  is  a  question  we  cannot  answer,  but  in  this 
report  they have been selected for purposes of strain  differentiation 
and classification.  In this respect we believe our results are informa- 
tive, not only in the differentiation and classification of strains but also 
on the  nature  of the differences between them.  Most prominent  is 
the fact that, on the basis of these reactions, those strains which have 
been subjected to the greatest number of monkey passages and which 
we had  termed passage  strains  (1),  do not  stand  in  sharp  contrast 
to  groups  of  more  recently  isolated  strains  which  we  had  termed 
human  strains.  There  is no  evidence in  these studies to show that 
the  immunological  make-up  of  the  strains  has  been  warped,  so  to 
speak, by adaptation to the host.  Similarities seem to exist between 
strains  isolated  from the  same.epidemic  rather  than  between those 
which  had  about  the  same  number  of passages.  That  is,  the  im- 
munological  reactions  tend  to  group  together  our  2  strains  isolated 
from the eastern epidemic of 1931 in contrast to the 2 strains isolated 
from the western epidemic of 1934,  which also fall together.  Further- 
more,  there is no indication that the immunological reactions of our 
2 strains of 1931  (which have had more passages in the monkey than 
those isolated in 1934)  more nearly  simulate those of the older strains 
(Park  and  Aycock)  which  have  had  most  passages  of  all.  This  is 
n Recently, Dr. B. F. Howitt (Science, 1937, 85, 268), commenting on various 
differences between strains of the virus of poliomyelitis, stated that she had re- 
covered a peculiar strain  from the epidemic in  Sacramento,  California, during 
the winter of 1934.  The new strain  differed immunologicaUy  from one isolated 
in the summer of 1934 in San Francisco and also differed from her passage strain 
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contrary to a suggestion we once made when we had worked with but 
one pair of human strains  (1). 
There seems little  doubt that some epidemiological application is 
to  be  found in  the  immunological differences.  In  fact,  significant 
results have been obtained in neutralization tests in which multiple 
strains  were  used  with  human  sera  (1,  15,  23).  Consequently,  it 
would seem that the present conception of the relation of human im- 
munity  to  the  epidemiology of poliomyelitis,  which has  been  con- 
structed on the basis of neutralization tests performed with human 
sera  and  but  one  strain  of  the  virus,  will  have  to  be  modified in 
the light  of these  newer results.  In  this  connection it  is  of some 
interest that our sample of pooled convalescent sera, obtained from 
adults during the  1931 epidemic in New England, neutralized all of 
our 6  strains.  It should be noted again that the convalescent sera 
were collected from adults,  but  this  brings  up  many questions too 
numerous  and  too  complex  to  warrant  discussion here.  However, 
one point is obvious: that, in an effort to clarify the subject, the ex- 
tent to which  antibodies specific for a  local strain are  present in a 
given  population  should  be  contrasted  with  the  presence  of  anti- 
bodies for a  foreign strain, and vice versa.  It would seem more than 
probable  that there would be some overlapping of these antibodies, 
but such an experiment would also probably help towards explaining 
some of the paradoxes now existent in the subject of the relation of 
neutralizing antibodies to clinical and subclinical immunity to polio- 
myelitis. 
CONCLUSION 
Qualitative immunological differences exist between early passage 
strains or so  called human strains of the virus of poliomyelitis. 
These differences show a relationship to the epidemic source of the 
virus and are exemplified in this study by 4 strains isolated in different 
years during an eastern and western epidemic of poliomyelitis. e, 
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Further Notes on Certain Monkeys Shown in Appendix  A 
In the case of the We., Flexner, Aycock and Park strains,  fresh monkeys were 
used in the entire series of passages which furnished stocks of virus; with the McC. 
and Wfd.  strains,  some monkeys had been  used  before.  For the McC.  strain, 
monkey C 6-7 having failed to respond to the intranasal instillation  of McC. virus 
on Oct.  23,  1934, received  on Nov. 21,  1934, the  same  strain  intracerebraUy, 
became paralyzed and died Dec. 3, 1934, when the cord was harvested.  For the 
Wfd. strain,  monkey C 5-5 had failed to sicken after the intracerebral  inoculation 
on Aug. 22 and Sept. 26, of non-infective  material  collected Julyl 1934, in  Cali- 
fornia.  On Oct. 30,  1934, the Wfd. strain was inoculated  intracraniaUy  and on 
Nov. 10 C 5-5 was prostrate,  killed with ether and the cord harvested. 
Five of the 12 monkeys vaccinated for the purpose of producing antisera  had 
previously been used in a study in experimental  measles.  Of these  12 monkeys, 
C 6-2  (vaccinated  with formalinized  Park virus),  was the only one which pre- 
viously had received  material  connected  with poliomyelitis.  This monkey had 
failed  twice to respond  to intracerebral  inoculations  of preserved  monkey cord, 
presumably non-infective, from the 1931 and 1934 epidemics.  Serum of C 6-2 was 
used in 2 tests. 
In the 83 neutralization  tests  of the various  sera  (exclusive of titrations)  we 
employed  65 fresh monkeys and 18 monkeys which had previously  resisted  the 
inoculation  of  serum  virus  mixtures,  presumably  non-infective.  Of  the  18 
monkeys, 14 proved to be satisfactory because they developed the typical experi- 
mental disease in the tests; 2, 4-18 and 4-50, were probably satisfactory because 
they developed  the experimental  disease, but only after a prolonged incubation 
period, and 2, 4-71 and 4-93, proved that they had been unsatisfactory test animals 
by resisting subsequent  intracerebral  inoculation with active virus although they 
had remained  free of symptoms during  the neutralization  test.  However,  this 
doe~ not seriously affect the general results,  since the experiment  including 4-71 
was discarded because the protected control came down, and since the result with 
4-93 could be eliminated without affecting the direct comparison of the 1931 and 
1934 groups of virus. 
Histological examination  of all monkeys furnishing the stocks of virus revealed 
the typical lesion of poliomyelitis in the medulla and in the cervical, dorsal and 
lumbar levels of the spinal cord.  This was true also of all monkeys shown in the 
appendix  in so far as 21 of them were examined histologically after experimental 
poliomyelitis. °~ 
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Explanatory Note for Appendix B 
Appendix B  illustrates the series  of vaccinations and intracerebral reinocula- 
tions.  It can be seen that 3 vaccinated monkeys became paralyzed as a  result 
of the mere vaccinations and that the monkeys in general were not solidly im- 
munized by intracutaneous vaccination.  Thus, in the course of the intracerebral 
tests 12 of 14 vaccinated monkeys and 1 of 3 vaccinated and infected monkeys 
developed experimental poliomyelitis with paralysis.  In 8 instances this followed 
tests with strains homologous  to the vaccine and in 6 instances followed strains 
heterologous  to  the  vaccine.  The  totals  do  not  tally because  C  8-4  became 
paralyzed twice;  once after the homologous  strain and 5 months later,  after a 
heterologous  strain. 
It may be noted further,  that of 5 vaccinated and 2 vaccinated and infected 
monkeys which  proved to be immune to their homologous  strain,  6 were also 
immune to the other strain of their own group (i.e. Old;  1931 and 1934; groups 
established  on  the  basis  of the  cross neutralization  tests).  Of these  6  group 
immune monkeys, 4 subsequently were found to be susceptible to a strain of one 
of the other 2 groups.  Therefore these results seem to substantiate the immu- 
nological classification  described in the text, but their value is nullified because of 
the lack of controls for the interval of time which elapsed between vaccination and 
infecting intracerebral inoculation. 
BIBLIOGRAPHY 
1.  Paul, J. R., and Trask, J. D., J. Exp. Meg., 1935, 61, 447. 
2.  Trask, J. D., and Paul, J. R., J. Baa., 1936, 31, 527. 
3.  Harrington, H., in Poliomyelitis,  International Committee for the Study of 
Infantile Paralysis, Baltimore, 1932, Chapter III, 116. 
4.  Jungeblut, C. W., f . Infect. Dis., 1936, 58, 150. 
5.  Sabin, A. B., and Olitsky, P. K., J. Exp. Meg., 1936, 64, 739. 
6.  Olitsky, P. K., and Cox, H. R., J. Exp. Meg., 1936, 63, 109. 
7.  Hudson,  M.  P.,  Lennette,  E.  H., and  Gordon, F. B., f.  Am.  ]fled. Assn., 
1936, i06~ 2037. 
8.  (a)  Kramer,  S.  D.,  J. Immunol.,  1936, 31,  167.  (b)  Kramer,  S.  D.,  and 
Grossman,  L.  H.,  J.  Immunol.,  1936, 31,  183.  (c)  Kramer,  S.  D.,  J. 
Immunol.,  1936, 31,  191.  (d)  Kramer,  S.  D.,  Grossman,  L.  H.,  and 
I-Ioskwith, B., J. Immunol.,  1936, 31, 199. 
9.  Aycock, W. L., and Kagan, J. R., J. Immunol.,  1927, 14, 85. 
10.  Stewart, F. W., and Rhoads, C. P., J. Exp. Meg., 1929, 49, 959. 
11.  Kramer, S. D., Arc& Neurol. and Psychiat.,  1935, 33,  1371. 
12.  Brodie, M., J. Immunol.,  1935, 28, 1. 
13.  Paul, J. R., Trask, J. D., and Webster, L. T., )'. Exp. Meg., 1935, 62, 245. 
14.  Paul, J. R., and Trask, J. D., J. Exp. Meg., 1932, 56,319. 
15.  Paul, J. R., and Trask, J. D., Y. Exp. Meg., 1933, 58, 513. 704  VIRUSES OF  POLIOMYELITIS 
16. Aycock, W. L., personal communication. 
17. Kessel, J. F., Van Wart, R., Fisk, R. T., and Stimpert, F. D., Proc. Soc. Exp. 
Biol. and Med., 1936, 35j 326. 
18. Flexner, S., and Amoss, H. L., J. Exp. Med., 1924, 89, 625. 
19.  Rhoads, C. P., J. Exp. Med., 1930, 51, 1. 
20.  Burnet, F. M., and MacNamara, J., Brit. J. Exp. Path., 1931, 12, 57. 
21.  Weyer, E. R., Proc. Soc. Exp. Biol. and Med., 1931, 29, 289. 
22.  Flexner, S., J. Am. Med. Assn., 1932, 99, 1244. 
23. Trask, J. D., and Paul, J. R., J. Exp. Med., 1933, 58, 531. 